A carregar...

Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer

BACKGROUND: Complement is a central part of both the innate and adaptive immune response and its activation has traditionally been considered part of the immunosurveillance response against cancer. Its pro-inflammatory role and its contribution to the development of many illnesses associated with in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Downs-Canner, Stephanie, Magge, Deepa, Ravindranathan, Roshni, O’Malley, Mark E., Francis, Lily, Liu, Zuqiang, Guo, Z. Sheng, Obermajer, Natasa, Bartlett, David L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733728/
https://ncbi.nlm.nih.gov/pubmed/26289805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4778-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!